Global Dactinomycin Market Research Report 2023

Dactinomycin Market

Dactinomycin is a mixture of Streptomyces chrysomallus, mainly composed of C1, C2, C3 and D.Red or orange-yellow crystalline powder of madder.Soluble in ethanol, acetone and benzene.Its effect is similar to that of actinomycin, and it has a wide antitumor spectrum.In addition, also has the strong resistance bacteria, fungi and viruses.It is mainly used for Hodgkin's disease, nephroblastoma and leukemia in children.The toxic and side effects are similar to those of actinomycin, mainly myelosuppression and gastrointestinal reactions.Advanced malignant tumors, low red and white blood cells and pregnant women are contraindicated.

The global Dactinomycin market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Dactinomycin is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Dactinomycin is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Dactinomycin in Alkylating Agent is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Dactinomycin include AstraZeneca, GSK, Recordati Rare Diseases, Lundbeck, Merck, Prasco Laboratories, X-GEN Pharmaceuticals, Mylan Institutional and Bedford Pharmaceuticals, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Dactinomycin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dactinomycin.

The Dactinomycin market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Dactinomycin market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Dactinomycin companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

Scope of Dactinomycin Market Report

Core Chapters

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Dactinomycin Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Injection

1.2.3 Implants

1.3 Market by Application

1.3.1 Global Dactinomycin Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Alkylating Agent

1.3.3 Hormone

1.3.4 Plant Medicine

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Dactinomycin Market Perspective (2018-2029)

2.2 Dactinomycin Growth Trends by Region

2.2.1 Global Dactinomycin Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Dactinomycin Historic Market Size by Region (2018-2023)

2.2.3 Dactinomycin Forecasted Market Size by Region (2024-2029)

2.3 Dactinomycin Market Dynamics

2.3.1 Dactinomycin Industry Trends

2.3.2 Dactinomycin Market Drivers

2.3.3 Dactinomycin Market Challenges

2.3.4 Dactinomycin Market Restraints

3.1 Global Top Dactinomycin Players by Revenue

3.1.1 Global Top Dactinomycin Players by Revenue (2018-2023)

3.1.2 Global Dactinomycin Revenue Market Share by Players (2018-2023)

3.2 Global Dactinomycin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Dactinomycin Revenue

3.4 Global Dactinomycin Market Concentration Ratio

3.4.1 Global Dactinomycin Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Dactinomycin Revenue in 2022

3.5 Dactinomycin Key Players Head office and Area Served

3.6 Key Players Dactinomycin Product Solution and Service

3.7 Date of Enter into Dactinomycin Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Dactinomycin Historic Market Size by Type (2018-2023)

4.2 Global Dactinomycin Forecasted Market Size by Type (2024-2029)

5.1 Global Dactinomycin Historic Market Size by Application (2018-2023)

5.2 Global Dactinomycin Forecasted Market Size by Application (2024-2029)

6.1 North America Dactinomycin Market Size (2018-2029)

6.2 North America Dactinomycin Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Dactinomycin Market Size by Country (2018-2023)

6.4 North America Dactinomycin Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Dactinomycin Market Size (2018-2029)

7.2 Europe Dactinomycin Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Dactinomycin Market Size by Country (2018-2023)

7.4 Europe Dactinomycin Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Dactinomycin Market Size (2018-2029)

8.2 Asia-Pacific Dactinomycin Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Dactinomycin Market Size by Region (2018-2023)

8.4 Asia-Pacific Dactinomycin Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Dactinomycin Market Size (2018-2029)

9.2 Latin America Dactinomycin Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Dactinomycin Market Size by Country (2018-2023)

9.4 Latin America Dactinomycin Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Dactinomycin Market Size (2018-2029)

10.2 Middle East & Africa Dactinomycin Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Dactinomycin Market Size by Country (2018-2023)

10.4 Middle East & Africa Dactinomycin Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 AstraZeneca

11.1.1 AstraZeneca Company Detail

11.1.2 AstraZeneca Business Overview

11.1.3 AstraZeneca Dactinomycin Introduction

11.1.4 AstraZeneca Revenue in Dactinomycin Business (2018-2023)

11.1.5 AstraZeneca Recent Development

11.2 GSK

11.2.1 GSK Company Detail

11.2.2 GSK Business Overview

11.2.3 GSK Dactinomycin Introduction

11.2.4 GSK Revenue in Dactinomycin Business (2018-2023)

11.2.5 GSK Recent Development

11.3 Recordati Rare Diseases

11.3.1 Recordati Rare Diseases Company Detail

11.3.2 Recordati Rare Diseases Business Overview

11.3.3 Recordati Rare Diseases Dactinomycin Introduction

11.3.4 Recordati Rare Diseases Revenue in Dactinomycin Business (2018-2023)

11.3.5 Recordati Rare Diseases Recent Development

11.4 Lundbeck

11.4.1 Lundbeck Company Detail

11.4.2 Lundbeck Business Overview

11.4.3 Lundbeck Dactinomycin Introduction

11.4.4 Lundbeck Revenue in Dactinomycin Business (2018-2023)

11.4.5 Lundbeck Recent Development

11.5 Merck

11.5.1 Merck Company Detail

11.5.2 Merck Business Overview

11.5.3 Merck Dactinomycin Introduction

11.5.4 Merck Revenue in Dactinomycin Business (2018-2023)

11.5.5 Merck Recent Development

11.6 Prasco Laboratories

11.6.1 Prasco Laboratories Company Detail

11.6.2 Prasco Laboratories Business Overview

11.6.3 Prasco Laboratories Dactinomycin Introduction

11.6.4 Prasco Laboratories Revenue in Dactinomycin Business (2018-2023)

11.6.5 Prasco Laboratories Recent Development

11.7 X-GEN Pharmaceuticals

11.7.1 X-GEN Pharmaceuticals Company Detail

11.7.2 X-GEN Pharmaceuticals Business Overview

11.7.3 X-GEN Pharmaceuticals Dactinomycin Introduction

11.7.4 X-GEN Pharmaceuticals Revenue in Dactinomycin Business (2018-2023)

11.7.5 X-GEN Pharmaceuticals Recent Development

11.8 Mylan Institutional

11.8.1 Mylan Institutional Company Detail

11.8.2 Mylan Institutional Business Overview

11.8.3 Mylan Institutional Dactinomycin Introduction

11.8.4 Mylan Institutional Revenue in Dactinomycin Business (2018-2023)

11.8.5 Mylan Institutional Recent Development

11.9 Bedford Pharmaceuticals

11.9.1 Bedford Pharmaceuticals Company Detail

11.9.2 Bedford Pharmaceuticals Business Overview

11.9.3 Bedford Pharmaceuticals Dactinomycin Introduction

11.9.4 Bedford Pharmaceuticals Revenue in Dactinomycin Business (2018-2023)

11.9.5 Bedford Pharmaceuticals Recent Development

11.10 HISUN

11.10.1 HISUN Company Detail

11.10.2 HISUN Business Overview

11.10.3 HISUN Dactinomycin Introduction

11.10.4 HISUN Revenue in Dactinomycin Business (2018-2023)

11.10.5 HISUN Recent Development

11.11 Hainan Jinrui Pharmaceutical

11.11.1 Hainan Jinrui Pharmaceutical Company Detail

11.11.2 Hainan Jinrui Pharmaceutical Business Overview

11.11.3 Hainan Jinrui Pharmaceutical Dactinomycin Introduction

11.11.4 Hainan Jinrui Pharmaceutical Revenue in Dactinomycin Business (2018-2023)

11.11.5 Hainan Jinrui Pharmaceutical Recent Development

11.12 Qilu Pharmaceutical

11.12.1 Qilu Pharmaceutical Company Detail

11.12.2 Qilu Pharmaceutical Business Overview

11.12.3 Qilu Pharmaceutical Dactinomycin Introduction

11.12.4 Qilu Pharmaceutical Revenue in Dactinomycin Business (2018-2023)

11.12.5 Qilu Pharmaceutical Recent Development

11.13 Shanghai Zhongke Pharmaceutical

11.13.1 Shanghai Zhongke Pharmaceutical Company Detail

11.13.2 Shanghai Zhongke Pharmaceutical Business Overview

11.13.3 Shanghai Zhongke Pharmaceutical Dactinomycin Introduction

11.13.4 Shanghai Zhongke Pharmaceutical Revenue in Dactinomycin Business (2018-2023)

11.13.5 Shanghai Zhongke Pharmaceutical Recent Development

11.14 Shanghai Xinya Pharmaceutical

11.14.1 Shanghai Xinya Pharmaceutical Company Detail

11.14.2 Shanghai Xinya Pharmaceutical Business Overview

11.14.3 Shanghai Xinya Pharmaceutical Dactinomycin Introduction

11.14.4 Shanghai Xinya Pharmaceutical Revenue in Dactinomycin Business (2018-2023)

11.14.5 Shanghai Xinya Pharmaceutical Recent Development

11.15 Nantong Xinhe Biotechnology

11.15.1 Nantong Xinhe Biotechnology Company Detail

11.15.2 Nantong Xinhe Biotechnology Business Overview

11.15.3 Nantong Xinhe Biotechnology Dactinomycin Introduction

11.15.4 Nantong Xinhe Biotechnology Revenue in Dactinomycin Business (2018-2023)

11.15.5 Nantong Xinhe Biotechnology Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Dactinomycin Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Injection

    Table 3. Key Players of Implants

    Table 4. Global Dactinomycin Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 5. Global Dactinomycin Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Dactinomycin Market Size by Region (2018-2023) & (US$ Million)

    Table 7. Global Dactinomycin Market Share by Region (2018-2023)

    Table 8. Global Dactinomycin Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 9. Global Dactinomycin Market Share by Region (2024-2029)

    Table 10. Dactinomycin Market Trends

    Table 11. Dactinomycin Market Drivers

    Table 12. Dactinomycin Market Challenges

    Table 13. Dactinomycin Market Restraints

    Table 14. Global Dactinomycin Revenue by Players (2018-2023) & (US$ Million)

    Table 15. Global Dactinomycin Market Share by Players (2018-2023)

    Table 16. Global Top Dactinomycin Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dactinomycin as of 2022)

    Table 17. Ranking of Global Top Dactinomycin Companies by Revenue (US$ Million) in 2022

    Table 18. Global 5 Largest Players Market Share by Dactinomycin Revenue (CR5 and HHI) & (2018-2023)

    Table 19. Key Players Headquarters and Area Served

    Table 20. Key Players Dactinomycin Product Solution and Service

    Table 21. Date of Enter into Dactinomycin Market

    Table 22. Mergers & Acquisitions, Expansion Plans

    Table 23. Global Dactinomycin Market Size by Type (2018-2023) & (US$ Million)

    Table 24. Global Dactinomycin Revenue Market Share by Type (2018-2023)

    Table 25. Global Dactinomycin Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 26. Global Dactinomycin Revenue Market Share by Type (2024-2029)

    Table 27. Global Dactinomycin Market Size by Application (2018-2023) & (US$ Million)

    Table 28. Global Dactinomycin Revenue Market Share by Application (2018-2023)

    Table 29. Global Dactinomycin Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 30. Global Dactinomycin Revenue Market Share by Application (2024-2029)

    Table 31. North America Dactinomycin Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 32. North America Dactinomycin Market Size by Country (2018-2023) & (US$ Million)

    Table 33. North America Dactinomycin Market Size by Country (2024-2029) & (US$ Million)

    Table 34. Europe Dactinomycin Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 35. Europe Dactinomycin Market Size by Country (2018-2023) & (US$ Million)

    Table 36. Europe Dactinomycin Market Size by Country (2024-2029) & (US$ Million)

    Table 37. Asia-Pacific Dactinomycin Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 38. Asia-Pacific Dactinomycin Market Size by Region (2018-2023) & (US$ Million)

    Table 39. Asia-Pacific Dactinomycin Market Size by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Dactinomycin Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 41. Latin America Dactinomycin Market Size by Country (2018-2023) & (US$ Million)

    Table 42. Latin America Dactinomycin Market Size by Country (2024-2029) & (US$ Million)

    Table 43. Middle East & Africa Dactinomycin Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 44. Middle East & Africa Dactinomycin Market Size by Country (2018-2023) & (US$ Million)

    Table 45. Middle East & Africa Dactinomycin Market Size by Country (2024-2029) & (US$ Million)

    Table 46. AstraZeneca Company Detail

    Table 47. AstraZeneca Business Overview

    Table 48. AstraZeneca Dactinomycin Product

    Table 49. AstraZeneca Revenue in Dactinomycin Business (2018-2023) & (US$ Million)

    Table 50. AstraZeneca Recent Development

    Table 51. GSK Company Detail

    Table 52. GSK Business Overview

    Table 53. GSK Dactinomycin Product

    Table 54. GSK Revenue in Dactinomycin Business (2018-2023) & (US$ Million)

    Table 55. GSK Recent Development

    Table 56. Recordati Rare Diseases Company Detail

    Table 57. Recordati Rare Diseases Business Overview

    Table 58. Recordati Rare Diseases Dactinomycin Product

    Table 59. Recordati Rare Diseases Revenue in Dactinomycin Business (2018-2023) & (US$ Million)

    Table 60. Recordati Rare Diseases Recent Development

    Table 61. Lundbeck Company Detail

    Table 62. Lundbeck Business Overview

    Table 63. Lundbeck Dactinomycin Product

    Table 64. Lundbeck Revenue in Dactinomycin Business (2018-2023) & (US$ Million)

    Table 65. Lundbeck Recent Development

    Table 66. Merck Company Detail

    Table 67. Merck Business Overview

    Table 68. Merck Dactinomycin Product

    Table 69. Merck Revenue in Dactinomycin Business (2018-2023) & (US$ Million)

    Table 70. Merck Recent Development

    Table 71. Prasco Laboratories Company Detail

    Table 72. Prasco Laboratories Business Overview

    Table 73. Prasco Laboratories Dactinomycin Product

    Table 74. Prasco Laboratories Revenue in Dactinomycin Business (2018-2023) & (US$ Million)

    Table 75. Prasco Laboratories Recent Development

    Table 76. X-GEN Pharmaceuticals Company Detail

    Table 77. X-GEN Pharmaceuticals Business Overview

    Table 78. X-GEN Pharmaceuticals Dactinomycin Product

    Table 79. X-GEN Pharmaceuticals Revenue in Dactinomycin Business (2018-2023) & (US$ Million)

    Table 80. X-GEN Pharmaceuticals Recent Development

    Table 81. Mylan Institutional Company Detail

    Table 82. Mylan Institutional Business Overview

    Table 83. Mylan Institutional Dactinomycin Product

    Table 84. Mylan Institutional Revenue in Dactinomycin Business (2018-2023) & (US$ Million)

    Table 85. Mylan Institutional Recent Development

    Table 86. Bedford Pharmaceuticals Company Detail

    Table 87. Bedford Pharmaceuticals Business Overview

    Table 88. Bedford Pharmaceuticals Dactinomycin Product

    Table 89. Bedford Pharmaceuticals Revenue in Dactinomycin Business (2018-2023) & (US$ Million)

    Table 90. Bedford Pharmaceuticals Recent Development

    Table 91. HISUN Company Detail

    Table 92. HISUN Business Overview

    Table 93. HISUN Dactinomycin Product

    Table 94. HISUN Revenue in Dactinomycin Business (2018-2023) & (US$ Million)

    Table 95. HISUN Recent Development

    Table 96. Hainan Jinrui Pharmaceutical Company Detail

    Table 97. Hainan Jinrui Pharmaceutical Business Overview

    Table 98. Hainan Jinrui Pharmaceutical Dactinomycin Product

    Table 99. Hainan Jinrui Pharmaceutical Revenue in Dactinomycin Business (2018-2023) & (US$ Million)

    Table 100. Hainan Jinrui Pharmaceutical Recent Development

    Table 101. Qilu Pharmaceutical Company Detail

    Table 102. Qilu Pharmaceutical Business Overview

    Table 103. Qilu Pharmaceutical Dactinomycin Product

    Table 104. Qilu Pharmaceutical Revenue in Dactinomycin Business (2018-2023) & (US$ Million)

    Table 105. Qilu Pharmaceutical Recent Development

    Table 106. Shanghai Zhongke Pharmaceutical Company Detail

    Table 107. Shanghai Zhongke Pharmaceutical Business Overview

    Table 108. Shanghai Zhongke Pharmaceutical Dactinomycin Product

    Table 109. Shanghai Zhongke Pharmaceutical Revenue in Dactinomycin Business (2018-2023) & (US$ Million)

    Table 110. Shanghai Zhongke Pharmaceutical Recent Development

    Table 111. Shanghai Xinya Pharmaceutical Company Detail

    Table 112. Shanghai Xinya Pharmaceutical Business Overview

    Table 113. Shanghai Xinya Pharmaceutical Dactinomycin Product

    Table 114. Shanghai Xinya Pharmaceutical Revenue in Dactinomycin Business (2018-2023) & (US$ Million)

    Table 115. Shanghai Xinya Pharmaceutical Recent Development

    Table 116. Nantong Xinhe Biotechnology Company Detail

    Table 117. Nantong Xinhe Biotechnology Business Overview

    Table 118. Nantong Xinhe Biotechnology Dactinomycin Product

    Table 119. Nantong Xinhe Biotechnology Revenue in Dactinomycin Business (2018-2023) & (US$ Million)

    Table 120. Nantong Xinhe Biotechnology Recent Development

    Table 121. Research Programs/Design for This Report

    Table 122. Key Data Information from Secondary Sources

    Table 123. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Dactinomycin Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Dactinomycin Market Share by Type: 2022 VS 2029

    Figure 3. Injection Features

    Figure 4. Implants Features

    Figure 5. Global Dactinomycin Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 6. Global Dactinomycin Market Share by Application: 2022 VS 2029

    Figure 7. Alkylating Agent Case Studies

    Figure 8. Hormone Case Studies

    Figure 9. Plant Medicine Case Studies

    Figure 10. Dactinomycin Report Years Considered

    Figure 11. Global Dactinomycin Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 12. Global Dactinomycin Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 13. Global Dactinomycin Market Share by Region: 2022 VS 2029

    Figure 14. Global Dactinomycin Market Share by Players in 2022

    Figure 15. Global Top Dactinomycin Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dactinomycin as of 2022)

    Figure 16. The Top 10 and 5 Players Market Share by Dactinomycin Revenue in 2022

    Figure 17. North America Dactinomycin Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 18. North America Dactinomycin Market Share by Country (2018-2029)

    Figure 19. United States Dactinomycin Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 20. Canada Dactinomycin Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. Europe Dactinomycin Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Europe Dactinomycin Market Share by Country (2018-2029)

    Figure 23. Germany Dactinomycin Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. France Dactinomycin Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. U.K. Dactinomycin Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. Italy Dactinomycin Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Russia Dactinomycin Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Nordic Countries Dactinomycin Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Asia-Pacific Dactinomycin Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Asia-Pacific Dactinomycin Market Share by Region (2018-2029)

    Figure 31. China Dactinomycin Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Japan Dactinomycin Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. South Korea Dactinomycin Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Southeast Asia Dactinomycin Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. India Dactinomycin Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Australia Dactinomycin Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Latin America Dactinomycin Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Latin America Dactinomycin Market Share by Country (2018-2029)

    Figure 39. Mexico Dactinomycin Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Brazil Dactinomycin Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Middle East & Africa Dactinomycin Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Middle East & Africa Dactinomycin Market Share by Country (2018-2029)

    Figure 43. Turkey Dactinomycin Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Saudi Arabia Dactinomycin Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. AstraZeneca Revenue Growth Rate in Dactinomycin Business (2018-2023)

    Figure 46. GSK Revenue Growth Rate in Dactinomycin Business (2018-2023)

    Figure 47. Recordati Rare Diseases Revenue Growth Rate in Dactinomycin Business (2018-2023)

    Figure 48. Lundbeck Revenue Growth Rate in Dactinomycin Business (2018-2023)

    Figure 49. Merck Revenue Growth Rate in Dactinomycin Business (2018-2023)

    Figure 50. Prasco Laboratories Revenue Growth Rate in Dactinomycin Business (2018-2023)

    Figure 51. X-GEN Pharmaceuticals Revenue Growth Rate in Dactinomycin Business (2018-2023)

    Figure 52. Mylan Institutional Revenue Growth Rate in Dactinomycin Business (2018-2023)

    Figure 53. Bedford Pharmaceuticals Revenue Growth Rate in Dactinomycin Business (2018-2023)

    Figure 54. HISUN Revenue Growth Rate in Dactinomycin Business (2018-2023)

    Figure 55. Hainan Jinrui Pharmaceutical Revenue Growth Rate in Dactinomycin Business (2018-2023)

    Figure 56. Qilu Pharmaceutical Revenue Growth Rate in Dactinomycin Business (2018-2023)

    Figure 57. Shanghai Zhongke Pharmaceutical Revenue Growth Rate in Dactinomycin Business (2018-2023)

    Figure 58. Shanghai Xinya Pharmaceutical Revenue Growth Rate in Dactinomycin Business (2018-2023)

    Figure 59. Nantong Xinhe Biotechnology Revenue Growth Rate in Dactinomycin Business (2018-2023)

    Figure 60. Bottom-up and Top-down Approaches for This Report

    Figure 61. Data Triangulation

    Figure 62. Key Executives Interviewed